DJIA 16,471.51 -171.50 -1.03%
NASDAQ 4,786.96 -41.37 -0.86%
S&P 500 1,969.98 -18.89 -0.95%
market minute promo

3.03 0.11 (3.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IDRA $3.03 3.77%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.92
Previous Close $2.92
Daily Range $2.90 - $3.20
52-Week Range $1.94 - $5.48
Market Cap $357.9M
P/E Ratio -6.08
Dividend (Yield) $0.00 (0.0%)
Volume 519,870
Average Daily Volume 1,783,064
Current FY EPS -$0.46

Sector

Healthcare

Industry

Drug Makers

Idera Pharmaceuticals, Inc. (IDRA) Description

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants. Website: http://www.iderapharma.com/

News & Commentary Rss Feed

5 Small Biotech Stocks That Could Get Hotter Than the August Heat

These small biotechs hold the potential to add sizzle to investors' portfolios.

3 Low-Price Biotech Stocks That Could Pop or Drop in 2016

Agenus Inc., Array BioPharma, and Idera Pharmaceuticals are expecting to release data from cancer drug trials in the coming year.

Idera Pharmaceuticals (IDRA) in Focus: Stock Jumps 5.3% - Tale of the Tape

Idera Pharmaceuticals (IDRA) Flagged As Strong On High Volume

Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: June 21 - 27

Idera Pharmaceuticals Announces Appointment of Mark J. Casey as General Counsel and Secretary of the

Idera Pharmaceuticals Announces Appointment of Mark J. Casey as General Counsel and Secretary of the Board of Directors

Mid-Afternoon Market Update: Standard Pacific Rises On Ryland Merger Deal; Micron Shares Slip

Mid-Day Market Update: DealerTrack Jumps On Acquisition News; AirMedia Shares Decline

Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage

Analysts Actions -- EMC, Micron, SanDisk and More

See More IDRA News...

IDRA's Top Competitors

IDRA $3.03 (3.77%)
Current stock: IDRA
AMGN $153.05 (-1.82%)
Current stock: AMGN
GILD $106.95 (-0.77%)
Current stock: GILD
BIIB $299.89 (-1.25%)
Current stock: BIIB